Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint Expression
NCT04872023
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
OTHER:
Blood and bone marrow sampling
Sponsor
Rennes University Hospital